Clinical Trials Browser

Phase 1/2 × Afatinib × 30 days × Clear all

NCT06648096 2026-05-27

AFAN

Phase 1/2 Recruiting

Classical hematologyHead & Neck

Squamous Cell Carcinoma of Head and Neck, Fanconi Anemia